摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-脱氧-4-氟-D-半乳糖 | 238418-56-9

中文名称
4-脱氧-4-氟-D-半乳糖
中文别名
——
英文名称
4-deoxy-4-fluoro-D-galactose
英文别名
4-deoxy-4-fluorogalactose;Gal4F;4-fluoro-D-4-deoxy-galactose;4-fluoro-ξ-D-4-deoxy-galactopyranose;4-fluorogalactose;4-Fluoro-4-deoxy-D-galactopyranose;(3R,4R,5R,6R)-5-fluoro-6-(hydroxymethyl)oxane-2,3,4-triol
4-脱氧-4-氟-D-半乳糖化学式
CAS
238418-56-9
化学式
C6H11FO5
mdl
MFCD00057524
分子量
182.149
InChiKey
FIHYONSINSKFAH-SVZMEOIVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    370.1±42.0 °C(Predicted)
  • 密度:
    1.59±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -2.1
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    90.2
  • 氢给体数:
    4
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    4-脱氧-4-氟-D-半乳糖 在 lithium hydroxide 、 磷酸sodium acetate 作用下, 反应 5.33h, 生成 4-Deoxy-4-fluoro-β-D-glucopyranosyl
    参考文献:
    名称:
    Synthesis of UDP-4-deoxy-4-fluoroglucose and UDP-4-deoxy-4-fluorogalactose and their Interactions with Enzymes of Nucleotide Sugar Metabolism
    摘要:
    Fluorinated carbohydrates can be used as probes of enzymatic active sites. We report the synthesis of 4-deoxy-4-fluoro-alpha-D-galactose-1-phosphate and the substrate analogues of UDP-galactose, UDP-4-deoxy-4-fluoro-alpha-D-galactose (UDP-FGal), and of UDP-glucose, UDP-4-deoxy-4-fluoro-alpha-D-glucose (UDP-FGlc), which may be useful in analyzing the binding properties of enzymes that utilize nucleotide sugars as substrates. As a first step in this study, we determine the kinetic and inhibition parameters for UDP-FGal and UDP-FGlc interacting with UDP-glucose dehydrogenase and UDP-galactose 4-epimerase. UDP-FGlc is a substrate for bovine liver UDP-glucose dehydrogenase: K-m = 30.2 +/- 4.5 mu M slightly higher than the value 9.6 +/- 0.7 mu M for UDP-glucose, and V-mUDP-FGlc = 046V (mUDP-Glc). UDP-FGal is not a substrate for UDP-glucose dehydrogenase but is a competitive inhibitor with respect to UDP-glucose (K-i = 19.9 +/- 6.6 mu M). These analogs also bind to UDP-galactose 4-epimerase from E. coli with dissociation constants K-d of 1.4 and 1.1 mM for UDP-FGlc and UDP-FGal, respectively.
    DOI:
    10.1021/jo00102a024
  • 作为产物:
    描述:
    1-硫代-b-甲基葡萄糖甙-4-甲基苯酯吡啶4-二甲氨基吡啶N-碘代丁二酰亚胺三氟甲磺酸酐 、 silica gel supported sodium hydrogen sulfate 、 β-galactosidase from bovine testes 、 sodium methylatesilver trifluoromethanesulfonate对甲苯磺酸溶剂黄146bovine serum albumin 作用下, 以 甲醇二氯甲烷N,N-二甲基甲酰胺乙腈 为溶剂, 反应 134.0h, 生成 4-脱氧-4-氟-D-半乳糖
    参考文献:
    名称:
    Synthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4’-deoxy-4’-fluoro-Thomsen–Friedenreich epitope
    摘要:
    选择性抗癌疫苗的开发,提供增强对肿瘤复发和转移的保护,一直是科学界研究的焦点。与肿瘤相关的糖蛋白MUC1代表了癌症免疫疗法的一个成熟靶点,并已被用于构建各种合成疫苗候选物。然而,许多这些疫苗原型存在固有的低免疫原性,并容易在体内迅速降解。为了克服这些缺点,已制备了新型氟化MUC1糖肽-BSA/TTox结合疫苗。用4’F-TF-MUC1-TTox结合物免疫小鼠导致强烈的免疫反应,覆盖了对MUC1的自然耐受性,并产生了选择性的IgG抗体,与MCF-7人类癌细胞上的原生MUC1表位发生交叉反应。
    DOI:
    10.3762/bjoc.11.15
点击查看最新优质反应信息

文献信息

  • Characterisation of a Bacterial Galactokinase with High Activity and Broad Substrate Tolerance for Chemoenzymatic Synthesis of 6-Aminogalactose-1-Phosphate and Analogues
    作者:Kun Huang、Fabio Parmeggiani、Edward Pallister、Chuen-Jiuan Huang、Fang-Fang Liu、Qian Li、William R. Birmingham、Peter Both、Baptiste Thomas、Li Liu、Josef Voglmeir、Sabine L. Flitsch
    DOI:10.1002/cbic.201700477
    日期:2018.2.16
    Furnishing phosphates: A galactokinase from L. grimontii (LgGalK) has been identified and characterised; it shows broad substrate specificity towards different nucleotide phosphates and monosaccharides. This enzyme, in combination with a galactose oxidase variant was used in the chemoenzymatic synthesis of a panel of 6‐aminogalactose‐1‐phosphate analogues.
    提供磷酸盐:已经鉴定并鉴定了来自格氏乳杆菌的半乳糖激酶(LgGalK);它对不同的核苷酸磷酸单糖显示出广泛的底物特异性。该酶与半乳糖氧化酶变体结合在一起,用于化学酶合成6-半乳糖-1-磷酸类似物。
  • SUGAR CHAIN CONTAINING 4-POSITION HALOGENATED GALACTOSE AND APPLICATION THEREOF
    申请人:Nishimura Shin-Ichiro
    公开号:US20090018327A1
    公开(公告)日:2009-01-15
    The present invention is directed to, for example, an oligosaccharide having at an end thereof a 4-position halogenated galactose residue represented by formula (I): (wherein X represents a halogen atom, and R represents a monosaccharide, an oligosaccharide, or a carrier), a transferase inhibitor containing the oligosaccharide, and a method for inhibiting sugar chain elongation reaction in the presence of glycosyltransferase, the method including employing the inhibitor. The invention also provides a method for producing a 4-position halogenated galactose sugar nucleotide represented by formula (II): (wherein each of R 1 to R 3 represents a hydroxyl group, an acetyl group, a halogen atom, or a hydrogen atom; X represents a halogen atom; and M represents a hydrogen ion or a metal ion), wherein the method employs bacterium-derived galactokinase and bacterium-derived hexose-1-phosphate uridylyltransferase. The invention is also directed to a sugar chain containing 4-position halogenated galactose envisaged to be employed as drugs and other materials, and to applications of the compound.
    本发明涉及一种寡糖,其末端具有由公式(I)表示的4位卤代半乳糖残基:(其中X代表卤素原子,R代表单糖寡糖或载体),含有该寡糖的转移酶抑制剂,以及在存在糖基转移酶时抑制糖链延长反应的方法,该方法包括使用该抑制剂。该发明还提供了一种生产由公式(II)表示的4位卤代半乳糖核苷酸的方法:(其中R1至R3中的每一个代表羟基、乙酰基、卤素原子或氢原子;X代表卤素原子;M代表氢离子或属离子),该方法利用细菌来源的半乳糖激酶和细菌来源的己糖-1-磷酸尿苷转移酶。本发明还涉及一种含有4位卤代半乳糖的糖链,可用作药物和其他材料,并涉及该化合物的应用。
  • Rapid Screening of Diverse Biotransformations for Enzyme Evolution
    作者:Emily E. Kempa、James L. Galman、Fabio Parmeggiani、James R. Marshall、Julien Malassis、Clement Q. Fontenelle、Jean-Baptiste Vendeville、Bruno Linclau、Simon J. Charnock、Sabine L. Flitsch、Nicholas J. Turner、Perdita E. Barran
    DOI:10.1021/jacsau.1c00027
    日期:2021.4.26
    of enzymes, in different formats, achieving sample throughputs equivalent to ∼40 s per sample. The heat map output allows rapid selection of active enzymes within 96-well plates facilitating identification of industrially relevant biocatalysts. This DiBT-MS screening workflow has been applied to the directed evolution of a phenylalanine ammonia lyase (PAL) as a case study, enhancing its activity toward
    缺乏无标签的高通量筛选技术的缺乏成为鉴定活性和选择性生物催化剂的主要瓶颈,变异体的数量通常超过了传统分析平台在实际时间范围内评估其活性的能力。在这里,我们展示了将生物转化直接输注到质谱仪(DiBT-MS)筛查中应用到各种格式的多种酶的过程,每个样品的样品通量约为40 s。热图输出允许在96孔板内快速选择活性酶,从而有助于鉴定工业上相关的生物催化剂。作为案例研究,该DiBT-MS筛选工作流程已应用于苯丙裂合酶(PAL)的定向进化,增强了其对富含电子的肉桂酸生物的活性,这些衍生物木质纤维素生物质的降解有关。筛选平台的其他好处包括发现具有新颖活性的生物催化剂(激酶,亚胺还原酶),并引入了离子迁移技术,可以更加可靠地鉴定产品。
查看更多